Academic Journals Database
Disseminating quality controlled scientific knowledge

Soluble CD26 and CD30 Plasma Levels in HIV Infected Patients with and Without GB Virus Type C Coinfection

Author(s): Haji-Molla-Hoseini Mostafa | Pourfathollah Ali-Akbar | Soheili Zahra | Mohraz Minoo | Amini Sedigheh | Aghaiepour Mahnaz | Samiee Shahram | Nikoogoftar Mahin | Moghtadaie Mina

Journal: Pakistan Journal of Biological Sciences
ISSN 1028-8880

Volume: 10;
Issue: 12;
Start page: 2014;
Date: 2007;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

Keywords: GB virus C | HIV | sCD26 | sCD30 | coinfection

GB virus type C (GBV-C) probably influences HIV infection associated disease by either directly inhibiting HIV replication or enhancing the immune competence to cope with HIV. Still the definitive mechanisms of this inhibitory effect need to be identified. To address the possibility of immune modulating effects of GBV-C coinfection in HIV patients we evaluated plasma levels of soluble (s) CD26 and CD30 in HIV infected patients with and without GBV-C. Cross-sectional comparison of sCD26 and sCD30 levels among 6 HIV/GBV-C coinfected, 11 HIV mono-infected and 13 healthy controls was carried out. We used a commercial EIA to evaluate sCD26 and scD30 and a RT-PCR assay to detect active GBV-C infection. The Mann-Whitney U test was used for statistical analysis. No statistically significant differences were observed in levels of sCD26 and sCD30 in plasma of HIV infected patients with and without GBV-C viremia. GBV-C infection does not appear to influence the sCD26 and sCD30 levels.
Affiliate Program     

Tango Jona
Tangokurs Rapperswil-Jona